Alzheimer’s Awareness Month: Q&A with Dr Sabina Brennan September is World Alzheimer’s Month. Alzheimer’s Disease (AD) is the most well-known form of dementia. Dementia is the collective name for progressive brain conditions affecting memory, thinking, behavior and emotions. Dementia affects almost 50 million people worldwide. While aging is a major risk factor for dementia, it also affects people under 65 years. There are over 100 forms of
Webinar: Where in the world should I locate my pivotal clinical trial? We are pleased to share with you news of an upcoming webinar featuring Cromos Pharma’s CEO Vlad Bogin, M.D, FACP. The live webinar “Where in the world should I locate my pivotal clinical trial?”, hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics, will take place 12 pm (Eastern Time) on Wednesday 16 September. Cromos Pharma has developed a
Clinical characteristics of dermatologic manifestations of COVID‐19 infection Skin rashes have been frequently described in patients with COVID-19. This article co-authored by Cromos Pharma CEO Dr Vlad Bogin and published in the International Journal of Dermatology (3 July 2020) examines the dermatologic manifestations of COVID-19. It includes a case series of 15 patients, review of literature, and proposed etiological classification. Read the full article here
